Deepak Singodia

Title: Deepak Singodia: Innovator in Pharmaceutical Formulations

Introduction

Deepak Singodia is a notable inventor based in Baroda, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. With a total of 4 patents to his name, Singodia's work has the potential to impact patient care and medication delivery.

Latest Patents

One of his latest patents is titled "Parenteral unit dosage form of dihydroergotamine." This patent describes a parenteral unit dosage form that comprises an aqueous solution of dihydroergotamine or a pharmaceutically acceptable salt as the sole active ingredient. The formulation includes one or more pH adjusting agents and optionally one or more co-solvents. The pH of the aqueous solution is designed to contain substantially lower amounts of impurities compared to solutions with a pH of 4.0 or less, especially when stored under specific conditions for at least three months.

Career Highlights

Throughout his career, Deepak Singodia has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Sun Pharmaceutical Industries Limited and Pharmaceutical Industries Limited. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and innovations.

Collaborations

Some of his notable coworkers include Alpesh Goyani and Bhaskar Pallerla. Their collaboration has likely fostered an environment of innovation and shared knowledge in the field of pharmaceuticals.

Conclusion

Deepak Singodia's contributions to pharmaceutical innovations, particularly in the area of parenteral dosage forms, highlight his role as a significant inventor in the industry. His patents reflect a commitment to improving medication delivery and patient outcomes.